Imricor Medical Systems (ASX:IMR) FCF Margin % : -1,625.52% (As of Dec. 2023)

View and export this data going back to 2019. Start your Free Trial

What is Imricor Medical Systems FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Imricor Medical Systems's Free Cash Flow for the six months ended in Dec. 2023 was A$-10.13 Mil. Imricor Medical Systems's Revenue for the six months ended in Dec. 2023 was A$0.62 Mil. Therefore, Imricor Medical Systems's FCF Margin % for the quarter that ended in Dec. 2023 was -1,625.52%.

As of today, Imricor Medical Systems's current FCF Yield % is -21.37%.

The historical rank and industry rank for Imricor Medical Systems's FCF Margin % or its related term are showing as below:

ASX:IMR' s FCF Margin % Range Over the Past 10 Years
Min: -2602.77 Med: -2053.1 Max: -1093
Current: -2117.93

During the past 6 years, the highest FCF Margin % of Imricor Medical Systems was -1093.00%. The lowest was -2602.77%. And the median was -2053.10%.

ASX:IMR's FCF Margin % is ranked worse than
94.69% of 828 companies
in the Medical Devices & Instruments industry
Industry Median: -7.525 vs ASX:IMR: -2117.93

Imricor Medical Systems FCF Margin % Historical Data

The historical data trend for Imricor Medical Systems's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Imricor Medical Systems FCF Margin % Chart

Imricor Medical Systems Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

-1,093.00

-1,848.50

-2,602.77

-2,053.10

-2,120.87

Imricor Medical Systems Semi-Annual Data
	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
FCF Margin %	Get a 7-Day Free Trial				-2,653.80	-1,604.18	-2,918.69	-3,150.84	-1,625.52

Competitive Comparison of Imricor Medical Systems's FCF Margin %

For the Medical Devices subindustry, Imricor Medical Systems's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Imricor Medical Systems's FCF Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Imricor Medical Systems's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Imricor Medical Systems's FCF Margin % falls into.

Imricor Medical Systems FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Imricor Medical Systems's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-19.512	/	0.92
	=	-2,120.87 %

Imricor Medical Systems's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	-10.127	/	0.623
	=	-1,625.52 %

Imricor Medical Systems FCF Margin % Related Terms

Thank you for viewing the detailed overview of Imricor Medical Systems's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Imricor Medical Systems (ASX:IMR) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Imricor Medical Systems Inc (ASX:IMR) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

400 Gateway Boulevard, Burnsville, MN, USA, 55337

Website

https://www.imricor.com

Imricor Medical Systems Inc is a medical device company engaged in addressing issues with traditional x-ray-guided ablation procedures through the development of MRI-guided technology. The products of the company include Advantage-MR EP Recorder/Stimulator, Vision-MR Ablation Catheter and Vision-MR Dispersive Electrode.

Imricor Medical Systems (ASX:IMR) Headlines

No Headlines